Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Frazier Healthcare acquires Catalent's U.S. commercial packaging
June 21, 2012
By: Gil Roth
President, Pharma & Biopharma Outsourcing Association
Frazier Healthcare has completed its acquisition of the U.S. commercial pharmaceutical packaging operations of Catalent Pharma Solutions. The new business will be operated as Packaging Coordinators, Inc. (PCI), the former name of that business. PCI will be led by Bill Mitchell, who was president of that business from 2002 to 2006 and will now serve as president and chief executive officer. Re-joining Mr. Mitchell as part of the new PCI management team are Bill Bolding, as chief operating officer, and Phil DiGiacomo, as vice president of sales, each of whom has a longstanding history of success in both the industry and with PCI. The new company will have operations in Philadelphia and Woodstock, IL. Mr. Mitchell commented, “This second act for PCI is not about nostalgia. We want to build on a strong foundation and reinvigorate PCI to once again become the supplier of choice for outsourced healthcare packaging. This management team knows growth is about focusing on the customer, including their mission-critical milestones, timelines and business needs. The products create and drive the opportunity. The attention to quality and the focus on meeting the customers current and future needs will drive our growth.” Frazier Healthcare, founded in 1991 to invest exclusively in healthcare, is a provider of growth equity and venture capital to high growth and emerging healthcare companies. “We are demonstrating our emphasis on a team approach at Frazier by empowering a known and passionate management team to create a reinvigorated model for healthcare packaging,” said Alan Frazier, managing partner of Frazier Healthcare. “The acquisition of PCI gives us the opportunity to extend our model of uncovering opportunities where the combination of new a management team and an infusion of capital can result in outstanding growth and market leadership.” “This sale is another step in advancing our strategy to focus on our leading drug development and delivery businesses in core segments,” said Barry Littlejohns, president of Catalent’s Medication Delivery Solutions segment. “We believe Frazier will be an excellent partner for the customers of the commercial packaging business.” PCI’s acquisition does not involve Catalent’s Clinical Supply Services operations adjacent to the Red Lion Road facility in Philadelphia, nor the Blow/Fill/Seal business in Woodstock.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !